Prediction of cardiovascular disease by abdominal obesity measures is dependent on body weight and sex - Results from two community based cohort studies

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 8, 2014, Pages 891-899

  Carlsson, A C ^a   Riserus, U ^b   Arnlov J ^b,c   Borne Y ^d   Leander, K ^a   Gigante, B ^a,b   Hellenius M L ^a   Bottai, M ^a   de Faire, U ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c DALARNA UNIVERSITY   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body mass index; Epidemiology; Gender; Incident cardiovascular disease; Sagittal abdominal diameter; Waist hip height ratio

Indexed keywords

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMMUNITY CARE; FEMALE; HIP CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUESTIONNAIRE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BODY MASS; CARDIOVASCULAR DISEASES; FOLLOW UP; OBESITY, ABDOMINAL; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SAGITTAL ABDOMINAL DIAMETER; SEX DIFFERENCE;

BODY MASS INDEX; BODY WEIGHT; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SAGITTAL ABDOMINAL DIAMETER; SEX FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84904749496     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.02.001     Document Type: Article

References (38)

1. Haslam D.W., James W.P. Obesity. Lancet 2005, 366:1197-1209.
2. Wandell P.E., Carlsson A.C., Theobald H. The association between BMI value and long-term mortality. Int J Obes (Lond) 2009, 33:577-582.
3. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg. Swed Br Med J Clin Res Ed 1984, 289:1257-1261.
4. Larsson B., Svardsudd K., Welin L., Wilhelmsen L., Bjorntorp P., Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J Clin Res Ed 1984, 288:1401-1404.
5. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 366:1640-1649.
6. Wormser D., Kaptoge S., Di Angelantonio E., Wood A.M., Pennells L., Thompson A., et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011, 377:1085-1095.
7. Carlsson A.C., Wandell P.E., de Faire U., Hellenius M.L. Risk factors associated with newly diagnosed high blood pressure in men and women. Am J Hypertens 2008, 21:771-777.
8. Carlsson A.C., Wandell P.E., Journath G., de Faire U., Hellenius M.L. Factors associated with uncontrolled hypertension and cardiovascular risk in hypertensive 60-year-old men and women - a population-based study. Hypertens Res 2009, 32:780-785.
9. Carlsson A.C., Wandell P.E., Halldin M., de Faire U., Hellenius M.L. Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women. Metab Syndr Relat Disord 2009, 7:231-241.
10. Riserus U., de Faire U., Berglund L., Hellenius M.L. Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk. J Obes 2010, 2010.
11. Iribarren C., Darbinian J.A., Lo J.C., Fireman B.H., Go A.S. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol 2006, 164:1150-1159.
12. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008, 359:2105-2120.
13. Carlsson A.C., Risérus U., Engström G., Ärnlöv J., Melander O., Leander K., et al. Novel and established anthropometric measures and the prediction of incident cardiovascular disease: a cohort study. Int J Obes (Lond) 2013, 37(12):1579-1585.
14. Carlsson A.C., Theobald H., Hellenius M.L., Wandell P.E. Cardiovascular and total mortality in men and women with different blood pressure levels - a 26-year follow-up. Blood Press 2009, 18:105-110.
15. Journath G., Hellenius M.L., Carlsson A.C., Wandell P.E., Nilsson P.M. Physicians' gender is associated with risk factor control in patients on antihypertensive and lipid lowering treatment. Blood Press 2010, 19:240-248.
16. Wandell P.E., Carlsson A.C., de Faire U., Hellenius M.L. Prevalence of blood lipid disturbances in Swedish and foreign-born 60-year-old men and women in Stockholm, Sweden. Nutr Metab Cardiovasc Dis 2011, 21:173-181.
17. Nordhamn K., Sodergren E., Olsson E., Karlstrom B., Vessby B., Berglund L. Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables. Int J Obes Relat Metab Disord 2000, 24:652-657.
18. Hedblad B., Nilsson P., Janzon L., Berglund G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet Med 2000, 17:299-307.
19. Li C., Engstrom G., Hedblad B., Calling S., Berglund G., Janzon L. Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study. Int J Obes (Lond) 2006, 30:1775-1781.
20. Melander O., Newton-Cheh C., Almgren P., Hedblad B., Berglund G., Engstrom G., et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. Jama 2009, 302:49-57.
21. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
22. Kerr K.F., McClelland R.L., Brown E.R., Lumley T. Evaluating the incremental value of new biomarkers with integrated discrimination improvement. Am J Epidemiol 2011, 174:364-374.
23. Bottai M., Zhang J. Laplace regression with censored data. Biom J 2010, 52:487-503.
24. Orsini N., Wolk A., Bottai M. Evaluating percentiles of survival. Epidemiology 2012, 23:770-771.
25. Wandell P., Carlsson A.C., Sundquist J., Johansson S.E., Bottai M., Sundquist K. Effects of prescribed antithrombotics and other cardiovascular pharmacotherapies on all-cause mortality in patients with diabetes and atrial fibrillation - a cohort study from Sweden using propensity score analyses. Diabetol Metab Syndr 2014, 6:2.
26. Clasey J.L., Bouchard C., Teates C.D., Riblett J.E., Thorner M.O., Hartman M.L., et al. The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes Res 1999, 7:256-264.
27. Kvist H., Chowdhury B., Grangard U., Tylen U., Sjostrom L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988, 48:1351-1361.
28. van der Kooy K., Leenen R., Seidell J.C., Deurenberg P., Visser M. Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry. Br J Nutr 1993, 70:47-58.
29. Bjorntorp P., Holm G., Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med 1999, 16:373-383.
30. Rutters F., Nieuwenhuizen A.G., Lemmens S.G., Bouwman F., Mariman E., Westerterp-Plantenga M.S. Associations between anthropometrical measurements, body composition, single-nucleotide polymorphisms of the hypothalamus/pituitary/adrenal (HPA) axis and HPA axis functioning. Clin Endocrinol (Oxf) 2011, 74:679-686.
31. Silventoinen K., Magnusson P.K., Tynelius P., Batty G.D., Rasmussen F. Association of body size and muscle strength with incidence of coronary heart disease and cerebrovascular diseases: a population-based cohort study of one million Swedish men. Int J Epidemiol 2009, 38:110-118.
32. Artero E.G., Lee D.C., Ruiz J.R., Sui X., Ortega F.B., Church T.S., et al. A prospective study of muscular strength and all-cause mortality in men with hypertension. J Am Coll Cardiol 2011, 57:1831-1837.
33. Ruiz J.R., Sui X., Lobelo F., Morrow J.R., Jackson A.W., Sjostrom M., et al. Association between muscular strength and mortality in men: prospective cohort study. BMJ 2008, 337:a439.
34. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003, 108:2317-2322.
35. Berg C., Rosengren A., Aires N., Lappas G., Toren K., Thelle D., et al. Trends in overweight and obesity from 1985 to 2002 in Goteborg, West Sweden. Int J Obes (Lond) 2005, 29:916-924.
36. Rosengren A., Eriksson H., Hansson P.O., Svardsudd K., Wilhelmsen L., Johansson S., et al. Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50. J Intern Med 2009, 266:268-276.
37. Rosengren A., Eriksson H., Larsson B., Svardsudd K., Tibblin G., Welin L., et al. Secular changes in cardiovascular risk factors over 30 years in Swedish men aged 50: the study of men born in 1913, 1923, 1933 and 1943. J Intern Med 2000, 247:111-118.
38. Almgren T., Wilhelmsen L., Samuelsson O., Himmelmann A., Rosengren A., Andersson O.K. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. J Hypertens 2007, 25:1311-1317.